06Jun
Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for pharmaceutical preemption. In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit’s holding that...
By:
Morrison & Foerster LLP - Class Dismissed
Related
What Constitutes Mass Shooting/Active Shooter Situation? Currently, there is no universally accepte...
Read More >
On December 16, 2019, the National Minimum Wage Commission (“CONASAMI” for its acronym in Spanish)...
Read More >
The National Labor Relations Board (“Board” or “NLRB”) has announced that it is publishing propo...
Read More >
On June 14, 2019, the United States Court of Appeals for the District of Columbia Circuit rejected t...
Read More >
Financial institutions M&A sector trends: consumer finance — H2 2019 and outlook for 2020 - Financ...
Read More >
The Arkansas Department of Energy and Environment – Division of Environmental Quality (“DEQ”) and...
Read More >